Sera Prognostics, Inc. (SERA) DCF Valuation

Valoración de DCF de Sera Prognostics, Inc. (SERA)

US | Healthcare | Medical - Diagnostics & Research | NASDAQ
Sera Prognostics, Inc. (SERA) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Sera Prognostics, Inc. (SERA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora DCF (suera)! Utilice datos financieros reales de los pronósticos de sueros, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de (SERA).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .1 .3 .3 .4 .7 1.0 1.4 2.0
Revenue Growth, % 0 -30.56 228 226.83 14.18 45.91 45.91 45.91 45.91 45.91
EBITDA -13.6 -17.1 -33.6 -42.9 -35.3 -.4 -.7 -1.0 -1.4 -2.0
EBITDA, % -37786.11 -68456 -40980.49 -16010.07 -11531.7 -100 -100 -100 -100 -100
Depreciation .9 .9 .7 1.2 .9 .4 .7 1.0 1.4 2.0
Depreciation, % 2627.78 3580 803.66 454.48 294.12 100 100 100 100 100
EBIT -14.5 -18.0 -34.3 -44.1 -36.2 -.4 -.7 -1.0 -1.4 -2.0
EBIT, % -40413.89 -72036 -41784.15 -16464.55 -11825.82 -100 -100 -100 -100 -100
Total Cash 21.4 13.5 105.1 82.7 49.1 .4 .7 1.0 1.4 2.0
Total Cash, percent .1 .1 .1 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 3.1 6.1 11.5
Account Receivables, % 2.78 8 3832.93 2280.97 3748.37
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0.00277778 0 0 0.000373134328 0 0.000630182421 0.000630182421 0.000630182421 0.000630182421 0.000630182421
Accounts Payable .7 .4 1.2 1.5 1.0 .4 .7 1.0 1.4 2.0
Accounts Payable, % 2077.78 1764 1459.76 577.61 341.83 100 100 100 100 100
Capital Expenditure -.1 -.1 -1.3 -.8 -.1 -.4 -.6 -.8 -1.2 -1.8
Capital Expenditure, % -302.78 -596 -1590.24 -295.15 -41.83 -88.37 -88.37 -88.37 -88.37 -88.37
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -18.0 -19.6 -35.5 -44.2 -36.2 -.4 -.7 -1.0 -1.4 -2.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -16.4 -19.2 -38.5 -46.4 -41.3 10.2 -.5 -.7 -1.1 -1.5
WACC, % 9.34 9.34 9.34 9.34 9.34 9.34 9.34 9.34 9.34 9.34
PV UFCF
SUM PV UFCF 6.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -2
Terminal Value -21
Present Terminal Value -14
Enterprise Value -7
Net Debt -2
Equity Value -5
Diluted Shares Outstanding, MM 31
Equity Value Per Share -0.16

What You Will Get

  • Editable Forecast Inputs: Easily adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Sera Prognostics, Inc.'s (SERA) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically for you.
  • Customizable and Professional: A refined Excel model that can be tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Customizable Forecast Inputs: Adjust essential parameters such as revenue growth, EBITDA %, and capital expenditures tailored for Sera Prognostics, Inc. (SERA).
  • Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics with precision.
  • High-Precision Accuracy: Leverages Sera Prognostics' real-world financial data for credible valuation results.
  • Effortless Scenario Analysis: Easily explore various assumptions and evaluate different outcomes.
  • Efficiency-Boosting Tool: Streamline your workflow by avoiding the complexity of building valuation models from the ground up.

How It Functions

  • Download: Obtain the pre-configured Excel file containing Sera Prognostics, Inc.'s (SERA) financial metrics.
  • Customize: Modify projections, including revenue growth rates, EBITDA percentages, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and evaluate results immediately.
  • Make Decisions: Leverage the valuation findings to inform your investment choices.

Why Choose This Calculator for Sera Prognostics, Inc. (SERA)?

  • Accurate Data: Utilize real Sera Prognostics financials for dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-constructed calculations streamline the process, so you don’t have to start from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
  • User-Friendly: Easy-to-navigate layout and clear, step-by-step guidance make it accessible for all users.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Sera Prognostics stock (SERA).
  • Financial Analysts: Enhance valuation processes with pre-built financial models tailored for Sera Prognostics.
  • Consultants: Provide clients with accurate valuation insights on Sera Prognostics quickly and effectively.
  • Business Owners: Gain insights into how companies like Sera Prognostics are valued to inform your own business strategies.
  • Finance Students: Explore valuation techniques using real-world data and case studies related to Sera Prognostics.

What the Template Contains

  • Pre-Filled DCF Model: Sera Prognostics’ financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Sera Prognostics’ profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.